Accelerate Diagnostics Inc.  – NasdaqCM: AXDX

The insiders have suddenly started huge buys and other acquisitions of shares of AXDX. Directors and board members have acquired 2, 153,650 shares valued at $17,528,114 during August as reported and found on InsiderInsights – see the link the sources section at the end of this article.

The best official news on AXDX is found in its 10-Q  for the period ending June 30, 2013. With its rights offering I am sure the Company was likely not wanting to complicate a rights offering with great press releases. We have to read into this one from the 10-Q, and from that filing we see they now have an abundance of cash on hand.

 

SEE AXDX IN STOCKGURU’S 12 BIOTECH BREAKOUT STOCKS

SEE THE ENTIRE LIST OF STOCKGURU’S 12 BIOTECH BREAKOUT STOCKS